Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$100.00K$100.00Kderived−27.0% vs Q4 2016 Net Income-$3.49M-$3.49MderivedN/M vs Q4 2016 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$3,523,000N/M Operating Cash Flowderived-$2,525,000N/M Free Cash Flowderived-$2,554,000— Margins · derivedOperating margin-3523.0%−988.7 pt vs Q4 2016
Net margin-3486.0%−871.4 pt vs Q4 2016
ended Dec 31, 2017 · filed Mar 16, 2018 · 75 d after period end